Just last week, the Food and Drug Administration (FDA) released a new warning for SGLT2 inhibitors, a class of drugs used to lower blood sugar in adults with type 2 diabetes. According to the FDA, a serious bacterial infection known as necrotizing fasciitis has been reported in the genital area of some patients taking SGLT2 inhibitors. While this condition is rare and only 12 cases have been confirmed since 2013, necrotizing fasciitis spreads rapidly and can be deadly. See More
Invokamet Latest News
Get the latest updates on this drug from the GoodRx medical team
Well-known for treating type 2 diabetes, Jardiance can also reduce the risk of a cardiovascular event by 38%—but it’s expensive. A 30-day supply costs well over $500, and many insurance plans won’t cover it. Luckily, there are ways for you to save as much as 100% off the cash price.
How much does Jardiance cost?
As of August 2018, the cash price for Jardiance is over $500 for 30 tablets. GoodRx discounts can help reduce this price a bit—to around $450—but that’s still way too much for most people. See More
This update is the result of new data from the CANVAS and CANVAS-R clinical trials. This research showed that leg and foot amputations occurred two times more often in patients treated with canagliflozin than in patients who were given a placebo sugar pill. See More
According to the FDA, canagliflozin and dapagliflozin may cause an increased risk of acute kidney injury. The previous warning for canagliflozin was for an increased risk of foot and leg amputations—all serious stuff. See More
The FDA has issued a safety alert for medications containing canagliflozin, a newer drug used to treat type 2 diabetes.
Do diabetics already have an increased risk of leg and foot amputations?
Yes. Diabetics have a higher risk of leg and foot amputations compared to a person who does not have diabetes. See More
It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.
Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More
On May 15, 2015, the FDA issued a warning for the newest class of diabetes medications, SGLT2 inhibitors.
According to the FDA, the medications in this class may lead to a serious and life-threatening condition known as ketoacidosis.
Which medications are considered SGLT2 inhibitors?
These medications also contain SGLT2 inhibitors in combination with other active ingredients:
- Glyxambi (empagliflozin/linagliptin)
- Invokamet (canagliflozin/metformin)
- Xigduo XR (dapagliflozin/metformin)
What should I do if I am taking one of these medications?
If you are taking one of the medications listed above DO NOT stop your medication without talking to your doctor. See More